A limited sampling strategy for determining carboplatin AUC and monitoring drug dosage

Author： Chatelut E.   Pivot X.   Otto J.   Chevreau C.   Thyss A.   Renee N.   Milano G.   Canal P.  

Publisher： Elsevier

ISSN： 0959-8049

Source： European Journal of Cancer, Vol.36, Iss.2, 2000-01, pp. : 264-269

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Carboplatin AUC 10 for IGCCCG good prognosis metastatic seminoma

By Tookman Laura   Rashid Sukaina   Matakidou Athena   Phillips Melissa   Wilson Peter   Ansell Wendy   Jamal-Hanjani Mariam   Chowdhury Simon   Harland Stephen   Sarwar Naveed   Oliver Timothy   Powles Thomas   Shamash Jonathan  

Acta Oncologica, Vol. 52, Iss. 5, 2013-06 ,pp. : 987-993

Informa Healthcare

Access to resources Recommend Favorite

Individual dosing of carboplatin based on drug monitoring in children receiving high-dose chemotherapy

By Rubie H.   Doz F.   Vassal G.   Chastagner P.   Gentet J.-C.   Urien S.   Bastian G.   Drouard-Troalen L.   Barberi-Heyob M.   Catalin J.   Chatelut E.   on behalf of Pharmacology Group of the Societe Francaise de Pediatrie Oncologique  

European Journal of Cancer, Vol. 39, Iss. 10, 2003-07 ,pp. : 1433-1438

Elsevier

Access to resources Recommend Favorite

A limited sampling strategy to estimate individual pharmacokinetic parameters of methotrexate in children with acute lymphoblastic leukemia

By Plard Christine   Bressolle Françoise   Fakhoury May   Zhang Daolun   Yacouben Karina   Rieutord André   Jacqz-Aigrain Evelyne  

Cancer Chemotherapy and Pharmacology, Vol. 60, Iss. 4, 2007-09 ,pp. : 621-621

Springer Publishing Company

Access to resources Recommend Favorite

A limited sampling strategy to estimate individual pharmacokinetic parameters of methotrexate in children with acute lymphoblastic leukemia

By Piard Christine   Bressolle Françoise   Fakhoury May   Zhang Daolun   Yacouben Karina   Rieutord André   Jacqz-Aigrain Evelyne  

Cancer Chemotherapy and Pharmacology, Vol. 60, Iss. 4, 2007-09 ,pp. : 609-620

Springer Publishing Company

Access to resources Recommend Favorite

Phase I Pharmacokinetics and Limited Sampling Strategies for the Bioreductive Alkylating Drug EO9

By EORTC Early Clinical Trials Group   McLeod H.L.   Graham M.A.   Aamdal S.   Setanoians A.   Groot Y.   Lund B.  

European Journal of Cancer, Vol. 32, Iss. 9, 1996-08 ,pp. : 1518-1522

Elsevier

Access to resources Recommend Favorite